Drug details

Targretin Gel (bexarotene gel)

type of Retinoid-like Agents, Topical

Targretin (bexarotene) 1% Gel is a retinoid used to treat skin lesions of cutaneous T-cell lymphoma (CTCL) (Stage 1A and 1B) in patients who have not responded to or not tolerated other therapies.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• itching,
• rash,
• burning,
• redness, and
• severe skin irritation,
• scaling of the skin

The following drugs are related to Targretin Gel, either as a replacement or used together:

• Soriatane (acitretin)
• Diprolene AF (betamethasone)
• Diprolene Lotion (betamethasone dipropionate)
• Diprolene Ointment (betamethasone dipropionate)
• Vegzelma (bevacizumab-adcd injection)
• Leukeran (chlorambucil)
• Cutivate Cream (fluticasone topical)
• Cutivate Lotion (fluticasone propionate lotion)
• Cutivate Ointment (fluticasone propionate ointment)
• Sotret (isotretinoin capsules)
• Istodax (romidepsin for injection)
• Neosalus Lotion (neosalus hydrating topical lotion)
• Triamcinolone Cream (triamcinolone acetonide cream)
• Triamcinolone Lotion (triamcinolone acetonide lotion)
• Triamcinolone Ointment (triamcinolone acetonide ointment)